DGAP-Stimmrechte: RHÖN-KLINIKUM AG (english)
RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG[the German Securities Trading Act] with the objective of Europe-wide
distribution
RHÖN-KLINIKUM AG
07.09.2012 09:50
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Notification according to section 26 para. 1 WpHG
UBS AG, Zurich, Switzerland, notified us pursuant to section 25 WpHG and
pursuant to section 25a WpHG of the following:
(1) UBS AG notified us pursuant to section 25 WpHG of the following:
On 31 August 2012, UBS AG exceeded the threshold of 5% of the voting rights
of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale,
Germany. On that date, UBS AG held 5.96% of the voting rights in
RHÖN-KLINIKUM AG (equals 8,237,442 voting rights).
From these voting rights a proportion of 0.81% (equals 1,115,734 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 5.15% (equals 7,121,708 voting rights) is based on
(financial/other) instruments pursuant to section 25 WpHG. From the voting
rights based on instruments pursuant to section 25 WpHG a proportion of
0.00% (equals 0 voting rights) is held indirectly. The exercise period of
the instruments pursuant to section 25 WpHG is at any time.
(2) UBS AG notified us pursuant to section 25a WpHG of the following:
On 31 August 2012, UBS AG exceeded the threshold of 5% of the voting rights
of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale,
Germany. On that date, UBS AG held 5.96% of the voting rights in
RHÖN-KLINIKUM AG (equals 8,238,693 voting rights).
On that date, the composition of the voting rights held by UBS AG was as
follows:
A proportion of 0.81% (equals 1,115,734 voting rights) was based on voting
rights pursuant to sections 21, 22 WpHG.
A proportion of 5.15% (equals 7,121,708 voting rights) was based on
(financial/other) instruments pursuant to section 25 WpHG. From the voting
rights based on instruments pursuant to section 25 WpHG a proportion of
0.00% (equals 0 voting rights) is held indirectly.
A proportion of 0.0009% (equals 1,251 voting rights) was based on
(financial/other) instruments pursuant to section 25a WpHG. From the voting
rights based on instruments pursuant to section 25a WpHG a proportion of
0.00% (equals 0 voting rights) is held indirectly. The (financial/other)
instruments pursuant to section 25a WpHG are described as
Equity Swaps with expiration date 4 February 2015.
Bad Neustadt a.d. Saale, 7 September 2012
The Board of Management
___________________________________________________________________________
Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax: +49 9771 99 - 1736
07.09.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Germany
Internet: www.rhoen-klinikum-ag.com
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Weitere Informationen: www.dpa-AFX.de
